secwatch.observer — SEC 8-K summary
======================================

Issuer:     ATOSSA THERAPEUTICS, INC. (ATOS)
CIK:        0001488039
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0001437749-23-012579
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Atossa Therapeutics reports 2023 annual meeting vote results; all proposals passed
--------------------------------------------------------------------------------

- Elected directors: Galli with 15,993,221 for, Steinhart with 22,292,391 for; broker non-votes ~30M.
- Ratified BDO USA as auditor for FY2023: 54,079,294 for, 1,607,433 against, 1,113,613 abstain.
- Advisory vote on executive compensation approved: 21,091,953 for, 4,707,752 against, 910,013 abstain.
- Total shares voted: 56,800,340 out of 126,624,110 entitled shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1488039/000143774923012579/0001437749-23-012579-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1488039/000143774923012579/atos20230502_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-012579

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer